HD Immune GmbH Foundation and Publication of Latest PreClinical Data
HD Immune GmbH HDI a privately held biotechnology company developing novel antibody treatments for Huntingtons Disease announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.
Stefan Bartl Lionel Wightman Austria Wirtschafts Service Austrian Centre Of Industrial Biotechnology University Of Natural Resources Life Sciences
Source: businesswireindia.com